Loading the section…
Company reports as filed with the U.S. Securities and Exchange Commission.
| Metric | 30/04/2025 | 30/04/2024 |
|---|---|---|
| Revenue | 57M | 50M |
| Cost of revenue | 28M | 29M |
| Research and development | 7M | 10M |
| Selling, general and administrative | 9M | 11M |
| Operating income | 5M | −7M |
| Pre-tax income | 5M | −7M |
| Income tax | −75,000 | −32,000 |
| Net income | 5M | −7M |
| Earnings per share | 0.34 | −0.54 |
| Earnings per share, diluted | 0.33 | −0.54 |
| Weighted average shares | 14M | 14M |
| Weighted average shares, diluted | 14M | 14M |
| Metric | 31/01/2026 | 31/10/2025 | 31/07/2025 | 30/04/2025 | 31/01/2025 | 31/10/2024 | 31/07/2024 | 30/04/2024 |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 7M | 9M | 10M | 10M | 3M | 3M | 3M | 3M |
| Receivables | 12M | 12M | 9M |
| Metric | 30/04/2025 | 30/04/2024 |
|---|---|---|
| Operating cash flow | 7M | −6M |
| Depreciation and amortisation | 2M | 2M |
| Share-based compensation | 654,000 | 1M |
| Capital expenditure | 389,000 | 836,000 |
| Investing cash flow | −389,000 | −836,000 |
| Share buybacks | 0 |
Amounts in USD unless stated otherwise. Data: US exchange trading and company filings with the regulator
| 11M |
| 16M |
| 10M |
| 9M |
| 10M |
| Current assets | 20M | 21M | 21M | 22M | 20M | 14M | 13M | 14M |
| Goodwill | 335,000 | 335,000 | 335,000 | 335,000 | 335,000 | 335,000 | 335,000 | 335,000 |
| Total assets | 28M | 30M | 31M | 32M | 31M | 25M | 25M | 26M |
| Current liabilities | 21M | 22M | 23M | 24M | 20M | 19M | 19M | 22M |
| Total liabilities | 24M | 26M | 27M | 29M | 25M | 25M | 25M | 28M |
| Equity | 4M | 4M | 4M | 4M | 5M | 681,000 | −332,000 | −2M |
| Shares outstanding | 14M | 14M | 14M | 14M | 14M | 14M | 14M | 14M |
| Shares issued | 14M | 14M | 14M | 14M | 14M | 14M | 14M | 14M |
| 634,000 |
| Financing cash flow | 170,000 | −527,000 |